Moolec Science SA Ordinary Shares (MLEC) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.318x

Based on the latest financial reports, Moolec Science SA Ordinary Shares (MLEC) has a cash flow conversion efficiency ratio of -0.318x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-890.48K) by net assets ($2.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MLEC equity to assets ratio to measure how much of total assets are equity-financed.

Moolec Science SA Ordinary Shares - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how Moolec Science SA Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Moolec Science SA Ordinary Shares cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Moolec Science SA Ordinary Shares Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Moolec Science SA Ordinary Shares ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
OurLiving AB
ST:OURLIV
-4.139x
Conferize A/S
CO:CONFRZ
-0.072x
Dangee Dums Limited
NSE:DANGEE
0.140x
Hapbee Technologies Inc
V:HAPB
0.329x
Samchai Steel Industries Public Company Limited
BK:SAM
-0.061x
Tianci International, Inc. Common Stock
NASDAQ:CIIT
-0.002x
Anagenics Ltd
AU:AN1
-0.286x
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
NASDAQ:HKPD
-0.018x

Annual Cash Flow Conversion Efficiency for Moolec Science SA Ordinary Shares (2021–2025)

The table below shows the annual cash flow conversion efficiency of Moolec Science SA Ordinary Shares from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see Moolec Science SA Ordinary Shares market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $-82.87 Million $-24.45 Million 0.295x +121.56%
2024-06-30 $6.82 Million $-9.33 Million -1.369x -84.14%
2023-06-30 $10.11 Million $-7.51 Million -0.743x -30.31%
2022-06-30 $1.60 Million $-915.08K -0.570x -868764.64%
2021-06-30 $134.08 Million $-8.80K 0.000x --

About Moolec Science SA Ordinary Shares

NASDAQ:MLEC USA Biotechnology
Market Cap
$4.89 Million
Market Cap Rank
#28588 Global
#5780 in USA
Share Price
$6.73
Change (1 day)
-6.53%
52-Week Range
$0.22 - $17.10
All Time High
$19.25
About

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more